Investors and Media
Press Releases
November 14, 2025
Scholar Rock Reports Third Quarter 2025 Financial Results and Recent Business Highlights
November 12, 2025
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 4, 2025
Scholar Rock to Present at the 2025 Jefferies Global Healthcare Conference
October 23, 2025
Scholar Rock to Report Third Quarter 2025 Financial Results on November 14, 2025
October 17, 2025
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 23, 2025
FDA Issues Complete Response Letter (CRL) for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA) Solely Related to Observations Identified at Catalent Indiana LLC Fill-Finish Facility
September 12, 2025
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 15, 2025
